Mylan’s Pay for CEO Bresch Grates on Lawmakers, Many InvestorsBy
Company touts ‘strong support’; voting tells another story
Executive scolded for ‘lavish compensation’ in hearing
Mylan NV Chief Executive Officer Heather Bresch was lambasted at a congressional hearing this week for taking home tens of millions of dollars as the company raised the price on its EpiPen allergy shot. Some investors have been critical of Mylan’s executive compensation for years.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.